Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026Business Wire · Oct 15, 2026
Rockwell Medical to Exhibit at ASN Kidney Week 2026Business Wire · Oct 14, 2026
Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' ListBusiness Wire · Oct 7, 2026
Reviewing Rockwell Medical (NASDAQ:RMTI) & Embecta (NASDAQ:EMBC)Defense World · Oct 1, 2026
Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call TranscriptSeeking Alpha · Aug 13, 2026
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research · Aug 13, 2026Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States and internationally. A key offering includes its Triferic line (Triferic Dialysate and Triferic AVNU), an innovative iron replacement therapy.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | -$0.24 | -$0.34 | Miss |
| May 7, 2026 | -$0.10 | -$0.40 | Miss |
| Mar 26, 2026 | $0.40 | -$0.10 | Miss |
| Nov 12, 2025 | -$0.40 | -$0.50 | Miss |
| Aug 14, 2025 | -$0.50 | -$0.50 | Beat |
| May 12, 2025 | -$0.30 | -$0.40 | Miss |